Cormorant Asset Management, LP's Form 4 filing
GreenLight Biosciences Holdings, PBCGRNA · filed Jul 24, 2023
- Accession no.
- 0000929638-23-002058
- Filed
- Jul 24, 2023, 4:01 PM ET
- Trade date
- Jul 20, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | Other: (See below) |
| Chen BihuaCIK 0001599214 | Other: (See below) |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | Other: (See below) |
| Cormorant Private Healthcare Fund II, LPCIK 0001747677 | Other: (See below) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2023 | Common Stock | SSaleDisposed | −9,188,659 | $0.00F1 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Pursuant to the terms of previously disclosed Contribution and Exchange Agreements, the shares reported herein were contributed to SW ParentCo, Inc. ("Parent") in exchange for shares of Series A-2 Preferred Stock, par value $0.001 per share, of Parent.
Referenced by the price of 1 transaction in Table I.
Remarks
The Reporting Persons may be deemed to be members of a "group" (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934) of persons that, in the aggregate, beneficially owned over 10% of the Issuer's Common Stock.